Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

MLA

Shumei Kato, et al. “Real-World Data from a Molecular Tumor Board Demonstrates Improved Outcomes with a Precision N-of-One Strategy.” Nature Communications, vol. 11, no. 1, Oct. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41467-020-18613-3.

APA

Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis J. Kuo, Ramez N. Eskander, Aaron Goodman, Natalie Galanina, Paul T. Fanta, Richard B. Schwab, Rebecca Shatsky, Steven C. Plaxe, Andrew Sharabi, Edward Stites, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, … Razelle Kurzrock. (2020). Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy. Nature Communications, 11(1), 1–9. https://doi.org/10.1038/s41467-020-18613-3

Chicago

Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis J. Kuo, et al. 2020. “Real-World Data from a Molecular Tumor Board Demonstrates Improved Outcomes with a Precision N-of-One Strategy.” Nature Communications 11 (1): 1–9. doi:10.1038/s41467-020-18613-3.